VEMLIDY 25MG TAB

Vemlidy 25mg Tablet is an antiviral medication containing tenofovir alafenamide, a nucleotide reverse transcriptase inhibitor indicated for chronic hepatitis B virus (HBV) infection management. This formulation delivers potent viral suppression with enhanced intracellular activation and improved renal and bone safety profiles compared to earlier tenofovir formulations. The 25mg dose provides effective HBV DNA reduction, helping to slow disease progression and reduce the risk of hepatic complications. Administered orally once daily, Vemlidy is suitable for treatment-naïve and treatment-experienced patients with chronic HBV. Requires regular monitoring of liver function and viral markers during therapy.